Injectable temperature-sensitive hydrogel wound dressing as well as preparation method and application thereof

By combining polydopamine, reduced graphene oxide and silver nanoclusters in wound dressing, the efficient bactericidal and sustained release effect on chronic wounds is achieved, solving the problems of mismatch in shape and poor antibacterial effects of existing dressings, and promoting wound healing , has excellent biocompatibility and electrical conductivity.

CN119055826APending Publication Date: 2024-12-03CIXI PEOPLES HOSPITAL MEDICAL HEALTH GRP (CIXI PEOPLES HOSPITAL) +2

Patent Information

Application Number
CN202411248827.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing wound dressings do not match the shape of the wound, have poor antibacterial effect, short age, poor ability to absorb wound exudates, and the use of antibiotics can easily lead to drug resistance and it is difficult to promote the healing of chronic wounds.

Method used

Develop an injectable thermosensitive hydrogel wound dressing, using silver nanoclusters to achieve short-term high-efficiency and long-term synergistic antibacterial combination by combining polydopamine and reduced graphene oxide as photothermal agents, combining bioactive glass and hydroxyethyl Cellulose enhances tissue adhesion and cell proliferation ability and has conductive functions.

Benefits of technology

It achieves short-term efficient bactericidal and long-term sustained release of chronic wounds, promotes cell proliferation and migration, improves wound healing speed, has excellent tissue adhesion, antibacteriality and biocompatibility, and reduces the risk of infection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055826A_ABST
    Figure CN119055826A_ABST
Patent Text Reader

Abstract

The invention discloses an injectable temperature-sensitive hydrogel wound dressing as well as a preparation method and application thereof. The preparation method comprises the following steps: preparing chitosan-coated silver nano-cluster microspheres AgNCs and bioactive glass BGs; the preparation method comprises the following steps: coating bioactive glass with dopamine hydrochloride, mixing the bioactive glass with a graphene oxide dispersion liquid, and carrying out an oxidation-reduction reaction to obtain rGO / BGs (at) PDA; hydroxyethyl cellulose, an aqueous dispersion of rGO / BGs (at) PDA and silver nanocluster microspheres AgNCs are added into a chitosan solution, then beta-sodium glycerophosphate is added, the mixed solution is stirred in an ice bath, and the injectable temperature-sensitive hydrogel wound dressing is obtained. According to the invention, polydopamine and reduced graphene oxide (rGO) are used as photothermal agents to realize synergistic antibiosis of a photothermal therapy and the silver nanoclusters with antibacterial efficacy, so that short-time efficient antibiosis and long-acting slow-release antibiosis are combined, and the finally obtained hydrogel has the functions of tissue adhesion, synergistic sterilization, anti-infection and tissue regeneration promotion; and a plurality of excellent functions such as free radical scavenging capacity and conductivity are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medical materials, and in particular to an injectable temperature-sensitive hydrogel wound dressing and a preparation method and application thereof. Background Art

[0002] The normal healing process of skin wounds mainly includes four programmed and overlapping stages: hemostasis, inflammation, cell proliferation, and tissue remodeling. However, when the wound is deep, large in area, or the patient has metabolic diseases such as diabetes, it is easy for the wound to stay in the inflammatory stage after completing the hemostasis stage and it is difficult to enter the next stage. The risk of bacterial infection increases, and wound infection will lead to excessive release of oxygen free radicals and various hydrolases, resulting in slow wound healing and affecting the migration of fibroblasts and the formation of new blood vessels. At present, the treatment methods for difficult-to-heal wounds mainly include surgical therapies such as debridement, flap transplantation, etc., and the use of dressings loaded with antibacterial drugs to prevent infection and accelerate healing. However, the dressings currently used have defects such as not matching the shape or depth of the wound, poor antibacterial effect and short duration, poor ability to absorb wound exudate, and easy secondary damage and infection when the dressing is changed, and lack of the function of promoting tissue regeneration. At the same time, excessive use of antibiotics will cause drug resistance. Therefore, it is urgent to develop wound dressings that are shape-plastic, biocompatible, anti-infective, anti-oxidant, and can promote tissue repair and regeneration, so as to help wounds accelerate the transition of the inflammatory stage and synergistically promote wound healing.

[0003] As a three-dimensional water-containing polymer network, hydrogel is very similar to the structure of the extracellular matrix. The network structure of hydrogel is adjustable, which is conducive to cell growth. At the same time, it can load active components such as antibacterial agents, growth factors, nano-functional materials, etc. It has the potential to promote wound healing with multifunctional synergy, and has become a research hotspot in the field of promoting chronic wound healing. Bioactive glass is an inorganic non-metallic material that can promote tissue repair and regeneration. It has good bioactivity, biocompatibility and controllable biodegradability. By forming a bond with the tissue, bioactive glass can form a close connection with the tissue, and its degradation products can also stimulate tissue regeneration. It has been widely used in many fields such as regenerative medicine, tissue engineering and wound repair. However, bioactive glass directly acts on the wound to release a large amount of alkaline ions, inhibiting cell proliferation and not conducive to the deposition of collagen.

[0004] CN114767923A discloses a composite hydrogel silver-loaded long-acting antibacterial dressing and its preparation method and application. The antibacterial dressing comprises the following components calculated in weight percentage: 1.5-6% oxidized sodium alginate, 3-9% chitosan derivative, 1-3% sodium alginate, 0.01-0.05% nano silver, and the balance is water. Sodium alginate sol coated with nano silver particles is introduced into the chemical cross-linked network structure of oxidized sodium alginate-chitosan derivative, the sodium alginate sol is interpenetrated in the chemical cross-linked network structure, the sodium alginate can stably coat the nano silver particles in the sodium alginate sol for a long time, and the sodium alginate sol also has good water absorption and good compatibility with the oxidized sodium alginate in the chemical cross-linked network structure, and the sodium alginate sol expands after absorbing water and can be more firmly fixed in the chemical cross-linked network structure of oxidized sodium alginate-chitosan derivative. However, in the early stages of the wound, the risk of infection by harmful bacteria is high and the number of bacteria is large after they proliferate. If short-term and efficient sterilization can be achieved, it will be more conducive to wound healing.

[0005] A study reported that (Tomar, Sarika, et al. "Multifunctional, Adhesive, and PDA-Coated Bioactive Glass Reinforced Composite Hydrogel for Regenerative Wound Healing.") used polydopamine (PDA) to coat bioactive glass to obtain a multifunctional composite hydrogel with high viscosity and the function of promoting angiogenesis and skin regeneration. However, it failed to achieve short-term high efficiency and long-term sustained-release bactericidal effects, and the bioactive glass coated with PDA also had the problem of uneven dispersion.

[0006] In view of the defects of the above-mentioned wound dressings, an injectable thermosensitive hydrogel wound dressing has been developed that has the functions of tissue adhesion, short-term and long-term synergistic sterilization using photothermal therapy and nanosilver, as well as promotion of cell proliferation and migration and electrical stimulation of tissue regeneration. This can achieve the purpose of treating chronic wound infection and promoting wound healing and regeneration, and has great clinical significance. Summary of the invention

[0007] In view of the deficiencies in the prior art, the present invention provides an injectable thermosensitive hydrogel wound dressing having tissue adhesion, short-term and long-term synergistic antibacterial effects. The dressing also has the functions of promoting cell proliferation and migration and conducting electricity, and has a positive effect on promoting the healing of chronic infected wounds, which is of great clinical significance.

[0008] To achieve the above object, the technical solution adopted by the present invention is:

[0009] A method for preparing an injectable temperature-sensitive hydrogel wound dressing comprises the following steps:

[0010] Step 1, after chitosan is dissolved, a soluble silver salt is added, a reducing agent is added dropwise to obtain silver nanoclusters, ethanol is added to precipitate the silver nanoclusters, a cross-linking agent is added to cross-link, and chitosan-wrapped silver nanocluster microspheres AgNCs are obtained by centrifugal purification and freeze-drying;

[0011] Step 2, mixing silicon dioxide, calcium carbonate, sodium carbonate and phosphorus pentoxide, heating and melting the mixture, and quenching the mixture with water to obtain silicate-based bioactive glass (BGs);

[0012] Step 3, dissolving dopamine hydrochloride in Tris-hydrochloride buffer, adding silicate-based bioactive glass powder thereto for polymerization reaction, and centrifuging, washing, and drying the product to obtain polydopamine-coated bioactive glass BGs@PDA;

[0013] Step 4, adding BGs@PDA to a graphene oxide (GO) dispersion and mixing the mixture to obtain rGO / BGs@PDA through a redox reaction;

[0014] Step 5, adding hydroxyethyl cellulose and rGO / BGs@PDA aqueous dispersion to the chitosan solution, then adding the AgNCs in step 1 and mixing, then adding sodium β-glycerophosphate, and stirring the mixed solution in an ice bath to obtain an injectable thermosensitive hydrogel wound dressing.

[0015] In the prior art, the main strategy for antibacterial wound dressings is to add antibiotics. Although they can play an antibacterial role, long-term use can easily cause skin irritation and drug resistance. In severe cases, the accumulation of drug ingredients may even cause unnecessary damage to the liver.

[0016] The present invention combines short-term and high-efficiency antibacterial with long-term sustained-release antibacterial, using polydopamine (PDA) and reduced graphene oxide (rGO) as photothermal agents to achieve short-term and high-efficiency antibacterial under photothermal therapy, and synergizing with silver nanoclusters with antibacterial efficacy to achieve long-term sustained-release antibacterial. In the hydrogel system, rGO can absorb 808nm near-infrared light and quickly heat up in a short time, thereby achieving efficient killing of bacteria, and the increased temperature can accelerate the conversion of the hydrogel dressing from liquid to gel state; at the same time, rGO can also promote the uniform dispersion of the bioactive glass wrapped in PDA, improve biocompatibility, and enable the hydrogel to have multiple excellent functions such as tissue adhesion, synergistic sterilization and anti-infection, and promotion of tissue regeneration, free radical scavenging ability and conductivity.

[0017] Preferably, the soluble silver salt includes one or more of silver nitrate or silver fluoroborate; the molar concentration of the silver salt in the solution is 1-5%;

[0018] The reducing agent includes one or more of sodium borohydride, potassium borohydride, citric acid, and ascorbic acid; the molar concentration of the reducing agent in the solution is 2-10%, and the molar ratio of the reducing agent to the silver ions in the soluble silver salt is 1.5-3:1;

[0019] The cross-linking agent includes one or more of glutaraldehyde and genipin; the molar concentration of the cross-linking agent in the solution is 0.1-0.5%;

[0020] In step 1, ethylenediaminetetraacetic acid (EDTA) is added to adjust the pH of the solution to promote the dissolution of chitosan, and the pH is adjusted to 3.5-4.5; the molar concentration of EDTA in the solution is 0.5-1%;

[0021] In step 1, the molecular weight of chitosan is 300-5000Da, and the mass concentration in the solution is 1-5%.

[0022] Preferably, in step 1, the reducing agent is added and the reaction is carried out at room temperature for 1-3 hours; and the cross-linking agent is added and the reaction is carried out at room temperature for 1-4 hours.

[0023] Preferably, in step 2, the mass ratio of silicon dioxide, calcium carbonate, sodium carbonate and phosphorus pentoxide is (40-50):(22-28):(22-28):(2-8); in step 2, the melting temperature is 1000-1300° C., and the melting time is 1-3 h.

[0024] Preferably, in step 3, the mass ratio of dopamine hydrochloride to bioactive glass is 1:2-4; and the polymerization reaction is carried out at room temperature for 8-24 hours.

[0025] Preferably, in step 4, the mass ratio of graphene oxide to BGs@PDA is 1-4:2-4; when the content of graphene oxide is high, the temperature of the hydrogel under photothermal therapy will rise rapidly, which may cause burns to the patient's wound, so the amount needs to be properly controlled. Further preferably, in step 4, the mass ratio of graphene oxide to BGs@PDA is 1:1.5-2.

[0026] The mixing includes one or more methods of ultrasound, vortex, and vibration.

[0027] The ultrasonic treatment is carried out at 50-100W for 10-60min; the vortex treatment time is 10-20min, and the shaking time is 30-60min.

[0028] Preferably, the solvent of the chitosan solution in step 5 is acetic acid, the deacetylation degree of the chitosan in step 5 is ≥95%, and the viscosity is 100-200 mPa.s;

[0029] Preferably, in step 5, the mass ratio of chitosan to hydroxyethyl cellulose is 8-10:1;

[0030] The mass concentration of chitosan in the mixed solution of step 5 is 1.5-2%; the mass concentration of hydroxyethyl cellulose is 0.1-0.5%; and the mass concentration of sodium β-glycerophosphate is 1-3%;

[0031] In step 5, after adding different raw materials, stir at room temperature for 30 min-2 h, add sodium β-glycerophosphate and stir and mix at 0-4° C. for 20 min-1 h, and store the product at 0-5° C. for later use.

[0032] The finally prepared injectable thermosensitive hydrogel wound dressing is used at 30-40°C and has a gelling time of 240-300s.

[0033] The present invention also provides an injectable temperature-sensitive hydrogel wound dressing prepared by the preparation method.

[0034] The present invention also provides the use of the injectable thermosensitive hydrogel wound dressing in the preparation of medical wound dressings. The hydrogel material has excellent tissue adhesion, electrical conductivity, antibacterial properties, injectability, free radical scavenging ability and biocompatibility, and can be used as a new wound dressing to treat various irregular infectious chronic wounds.

[0035] Preferably, the injectable thermosensitive hydrogel wound dressing is irradiated with infrared radiation after being attached to achieve short-term and efficient sterilization, and the irradiation power is 0.1-1W / cm 2 , the irradiation time is 100s-210s.

[0036] Compared with the prior art, the present invention has the following beneficial effects:

[0037] (1) The present invention combines short-term high-efficiency antibacterial with long-term sustained-release antibacterial, and uses photothermal therapy and silver nanoclusters (AgNCs) materials with antibacterial efficacy to achieve synergistic antibacterial. Polydopamine (PDA) and reduced graphene oxide (rGO) are used as photothermal agents in the hydrogel system. By absorbing 808nm near-infrared, the temperature can be quickly increased in a short time, effectively killing bacteria, and the increased temperature can accelerate the conversion of the hydrogel dressing from liquid to gel state. Ag NCs play a role in long-term sustained-release sterilization in the system, and have a fluorescent signal discernible to the naked eye under ultraviolet light. The hydrogel containing this material also has the function of fluorescent signal indication.

[0038] (2) The bioactive glass in the present invention can promote the proliferation and migration of wound cells, thereby promoting wound healing. At the same time, studies have shown that bioactive glass will be converted into a component similar to hydroxyapatite (HA) in human body fluids, and HA will promote cell proliferation and the secretion of growth factors. The use of PDA to wrap the bioactive glass in the system can slow down the release of alkaline ions, enhance the interaction between cells and materials, and also promote the conversion of bioactive glass into HA.

[0039] (3) The PDA-encapsulated bioactive glass (BGs@PDA) in the present invention is prone to sedimentation in the hydrogel system due to its large particle size. Therefore, BGs@PDA is loaded onto graphene oxide through a redox reaction to generate rGO / BGs@PDA, which can significantly improve the sedimentation phenomenon and make rGO / BGs@PDA evenly distributed in the hydrogel system.

[0040] (4) The hydrogel in the present invention is a thermosensitive hydrogel, which is a liquid at room temperature and transforms from a solution to a gel state when the temperature rises to above 37°. The polydopamine and graphene oxide contained in the hydrogel system are both photothermal materials, which can absorb 808nm near-infrared light and convert it into thermal energy and increase the temperature, thereby accelerating the phase transition of the hydrogel. BRIEF DESCRIPTION OF THE DRAWINGS

[0041] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for use in the embodiments of the present invention. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.

[0042] Figure 1 It is the ultraviolet absorption spectrum, fluorescence excitation spectrum and fluorescence emission spectrum of the AgNCs synthesized in step 1 of Example 2, as well as the spectrum of the AgNCs under 305nm ultraviolet irradiation.

[0043] Figure 2 is a scanning electron microscope image of the overall morphology of the silicate-based bioactive glass synthesized in step 2 of Example 2 ( Figure 2 A) and scanning electron microscopy images of the hydrogels prepared in Comparative Example 1 and Example 2 ( Figure 2 B).

[0044] Figure 3 This is the infrared absorption spectrum of the product synthesized in step 4 and step 5 of Example 2. Figure 3 A is the infrared absorption spectrum of GO before and after loading BGs@PDA in step 4 of Example 2; Figure 3 B is AgNCs and rGO in step 5 of Example 2 2 / Infrared absorption spectra of BGs@PDA4 and Example 2 hydrogel.

[0045] Figure 4 This is a graph showing the storage modulus and loss modulus of the hydrogels of Example 1, Example 2 and Example 4 measured using a rheometer.

[0046] Figure 5 The validation result of the injectability of the hydrogel in Example 2 is shown in FIG. Figure 5 A) and viscosity versus shear rate ( Figure 5 B).

[0047] Figure 6 The adhesion test result of the hydrogel in Example 2 is shown in FIG. Figure 6 A) Self-healing test results ( Figure 6 B) and the storage modulus and loss modulus results under different strain conditions ( Figure 6 C).

[0048] Figure 7 Dispersion diagram of BGs@PDA hydrogel and comparative example 2 hydrogel.

[0049] Figure 8 It is a temperature rise curve of the hydrogels of comparative example 1, BGs@PDA and examples 1, 2, 3, and 4 under 808 nm near-infrared light irradiation.

[0050] Fig. 9 It is a graph showing the free radical scavenging rate and conductivity test results of the hydrogels of Comparative Example 1 and Examples 1, 2, 3, and 4.

[0051] Fig.10 The diagram shows the antibacterial effect of co-culturing the hydrogels of Comparative Example 1 and Example 2 with Escherichia coli and Staphylococcus aureus, respectively.

[0052] Fig.11 The biocompatibility test results of the hydrogel synthesized in Example 2 are shown in FIG. Fig.11 A is a graph showing the test results of the effects of different concentrations of hydrogel extracts on 3T3 cell proliferation; Fig.11 B is the live / dead staining experimental results of co-culture of 3T3 cells with hydrogel extracts of different concentrations; Fig.11 C is the result of the scratch test of co-culture of 3T3 cells with hydrogel extracts of different concentrations; Fig.11 D is the blood compatibility test and hemolysis rate results of hydrogel extracts with different concentrations.

[0053] Fig.12 This is a diagram showing the effect of using the hydrogel in Example 2 as a wound dressing to promote wound healing. DETAILED DESCRIPTION

[0054] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with embodiment. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. Those skilled in the art can make modifications or equivalent substitutions based on the understanding of the technical scheme of the present invention without departing from the spirit and scope of the technical scheme of the present invention, and all should be included in the protection scope of the present invention.

[0055] The raw materials used in the following specific embodiments are all purchased from the market.

[0056] Comparative Example 1 Preparation of chitosan / hydroxyethyl cellulose / sodium glycerophosphate hydrogel

[0057] Step 1, synthesis of silver nanoclusters: 100 mg of chitosan with Mw: 800-1000 was added to 10 mL of a solution containing 0.5 mM AgNO3; 40 mg of EDTA was added to the solution to reduce the pH value of the solution to 3.5-4.5 to promote the dissolution of chitosan; 1 mL of NaBH4 (1.0 mM) solution was added dropwise and stirred at low speed for 2 h at room temperature to prepare AgNCs;

[0058] Then, ethanol was added dropwise to the mixed solution under stirring, and the solution was observed to change from a clear yellow solution to a milky yellow colloidal solution. 15 μL (20%) of cross-linking agent glutaraldehyde (GA) was added to the colloidal solution and reacted at room temperature for 2 h to obtain AgNCs. The AgNCs were purified by centrifugation three times and then collected and finally dispersed in deionized water and freeze-dried for later use.

[0059] Step 2, add 150 mg of chitosan (CS) with a deacetylation degree of ≥95% and a viscosity of 100-200 mPa.s to 9 mL of acetic acid solution with a concentration of 0.1 mM, and stir at a low speed for 2 hours; then add hydroxyethyl cellulose (HEC) with a mass ratio of 10:1 to chitosan, and stir at a low speed for 30 minutes;

[0060] Step 3, add 4 mg of AgNCs and 250 mg of sodium β-glycerophosphate (β-GP) dissolved in 1 mL of pure water, slowly add the prepared solution, and stir for 30 min under ice bath conditions; finally, transfer the solution to an EP tube and store at 4 °C for future use;

[0061] The mixed solution prepared in the above steps is injected into the wound site using an injection device, and the hydrogel dressing of any shape is obtained by gelling at the skin temperature to achieve accurate coverage of the wound. The prepared hydrogel has certain adhesion and antibacterial properties, but poor mechanical strength.

[0062] Example 1 Preparation of GO:BGs@PDA 2:2 hydrogel

[0063] Step 1, synthesis of silver nanoclusters: 100 mg of chitosan with Mw: 800-1000 was added to 10 mL of a solution containing 0.5 mM AgNO3; 40 mg of EDTA was added to the solution to reduce the pH value of the solution to 3.5-4.5 to promote the dissolution of chitosan; 1 mL of NaBH4 (1.0 mM) solution was added dropwise and stirred at low speed for 2 h at room temperature to prepare AgNCs;

[0064] Then, ethanol was added dropwise to the mixed solution under stirring, and the solution was observed to change from a clear yellow solution to a milky yellow colloidal solution. 15 μL (20%) of cross-linking agent glutaraldehyde (GA) was added to the colloidal solution and reacted at room temperature for 2 h to obtain AgNCs. The AgNCs were purified by centrifugation three times and then collected and finally dispersed in deionized water and freeze-dried for later use.

[0065] Step 2, preparation of bioactive glass: according to 45:24.5:24.5:6, silicon dioxide (SiO2), calcium carbonate (CaCO3), sodium carbonate (NaCO3), and phosphorus pentoxide (P2O5) are accurately weighed and put into a crucible, and the crucible is placed in a Mabo furnace, the maximum temperature is set to 1200°C, and heated for 2 hours; the liquid in the crucible in the furnace is quickly poured into distilled water at room temperature to cool down, and then the block of bioactive glass cooled to room temperature is dried in an oven at 100°C for 3 hours; the product is placed in a pulverizer and crushed, and then passed through a 500-mesh sieve to synthesize bioactive glass (BGs);

[0066] Step 3, synthesis of BGs@PDA: add 0.25 g dopamine hydrochloride (DA) to 50 mL, 10 mM Tris-HCl buffer (Tris-HCl), stir at low speed for 5 min at room temperature until the solution changes from transparent to dark brown; then add 0.5 g of the bioactive glass prepared in step 2, and stir vigorously at room temperature overnight; collect the solution by centrifugation and repeatedly rinse with pure water until the supernatant becomes colorless; dry the product after centrifugation at 50°C for 48 h to obtain BGs@PDA;

[0067] Step 4, preparation of rGO2 / BGs@PDA2: add 2 mg BGs@PDA to 1 mL of 2 mg / mL graphene oxide (GO) dispersion, and disperse it evenly by ultrasound (power of 40 W) for 10 min to obtain a dispersion of rGO2 / BGs@PDA2;

[0068] Step 5, preparation of hydrogel: add chitosan (CS) with a deacetylation degree ≥ 95% and a viscosity of 100-200 mPa.s to 8 mL of acetic acid solution with a concentration of 0.1 mM, and stir at low speed for 2 h; then add hydroxyethyl cellulose with a mass ratio of 10:1 to chitosan, and stir at low speed for 30 min; add the prepared rGO2 / BGs@PDA2 dispersion and 4 mg of AgNCs prepared in step 1, and stir at low speed for 1 h; then dissolve 150 mg of sodium β-glycerophosphate (β-GP) in 1 mL of pure water, slowly add the above prepared solution, and stir for 30 min under ice bath conditions to obtain a hydrogel; finally, transfer the solution to an EP tube and store it at 4°C for use;

[0069] The mixed solution prepared in the above steps is injected into the wound site using an injection device, and a hydrogel dressing of any shape is obtained by temperature change to achieve accurate coverage of the wound. The hydrogel prepared in Example 1 has better mechanical strength and adhesion performance, as well as biocompatibility than that in Comparative Example 1.

[0070] Example 2 Preparation of GO:BGs@PDA 2:4 hydrogel

[0071] Step 1, synthesis of silver nanoclusters: 100 mg of chitosan with Mw: 800-1000 was added to 10 mL of a solution containing 0.5 mM AgNO3; 40 mg of EDTA was added to the solution to reduce the pH value of the solution to 3.5-4.5 to promote the dissolution of chitosan; 1 mL of NaBH4 (1.0 mM) solution was added dropwise and stirred at low speed for 2 h at room temperature to prepare AgNCs;

[0072] Then, ethanol was added dropwise to the mixed solution under stirring, and the solution was observed to change from a clear yellow solution to a milky yellow colloidal solution. 15 μL (20%) of crosslinking agent glutaraldehyde (GA) was added to the colloidal solution and reacted at room temperature for 2 hours to obtain AgNCs nanoclusters. The AgNCs were purified by centrifugation three times and then collected. Finally, they were dispersed in deionized water and freeze-dried for later use. Its ultraviolet absorption spectrum and fluorescence spectrum, as well as the picture of silver nanoclusters under 305nm ultraviolet irradiation are shown in Figure 1. Figure 1 shown.

[0073] Step 2, preparation of bioactive glass: according to 45:24.5:24.5:6, silicon dioxide (SiO2), calcium carbonate (CaCO3), sodium carbonate (NaCO3), and phosphorus pentoxide (P2O5) are accurately weighed and put into a crucible, and the crucible is placed in a Mabo furnace, the maximum temperature is set to 1200°C, and heated for 2 hours; the liquid in the crucible in the furnace is quickly poured into distilled water at room temperature to cool down, and then the block of bioactive glass cooled to room temperature is dried in an oven at 100°C for 3 hours; the product is placed in a pulverizer and crushed, and then passed through a 500-mesh sieve to synthesize bioactive glass (BGs); the microscopic morphology of the obtained bioactive glass is shown in the scanning electron microscope image Figure 2 As shown, the scale bar on the left is 200 μm, and the scale bar on the right is an enlarged view with a scale bar of 1 μm.

[0074] Step 3, synthesis of BGs@PDA: add 0.25 g dopamine hydrochloride (DA) to 50 mL, 10 mM Tris-HCl buffer (Tris-HCl), stir at low speed for 5 min at room temperature until the solution changes from transparent to dark brown; then add 0.5 g of the bioactive glass prepared in step 2, and stir vigorously at room temperature overnight; collect the solution by centrifugation and repeatedly rinse with pure water until the supernatant becomes colorless; dry the product after centrifugation at 50°C for 48 h to obtain BGs@PDA;

[0075] Step 4, preparation of rGO2 / BGs@PDA4: 4 mg BGs@PDA was added to 1 mL of 2 mg / mL graphene oxide (GO) dispersion, and the dispersion was uniformly dispersed by ultrasound (power of 100 W) for 10 min to obtain a dispersion of rGO2 / BGs@PDA4; the infrared spectra before and after loading are shown in Figure 3 As shown, it can be seen that after loading BGs@PDA, graphene oxide (GO) was reduced to reduced graphene oxide (rGO).

[0076] Step 5, preparation of hydrogel: chitosan (CS) with a deacetylation degree of ≥95% and a viscosity of 100-200 mpa.s was added to 8 mL of acetic acid solution with a concentration of 0.1 mM, and stirred at low speed for 2 h; then hydroxyethyl cellulose was added in a mass ratio of 10:1 to chitosan, and stirred at low speed for 30 min; the prepared rGO2 / BGs@PDA4 dispersion and 4 mg of AgNCs prepared in step 1 were added, and stirred at low speed for 1 h; then 150 mg of sodium β-glycerophosphate (β-GP) was dissolved in 1 mL of pure water, and the prepared solution was slowly added, and stirred for 30 min under ice bath conditions to obtain a hydrogel; finally, the solution was transferred to an EP tube and stored at 4 ° C for use; the infrared spectra of AgNCs, rGO2 / BGs@PDA4 and the final product hydrogel (Hydrogel) are shown in Figure 3As shown, it can be seen that both raw materials are effectively cross-linked in the hydrogel network through hydrogen bonds.

[0077] The mixed solution prepared in the above steps is injected into the wound site using an injection device, and a hydrogel dressing of any shape is obtained by utilizing the temperature change to achieve accurate coverage of the wound. However, considering that when the temperature of the wound dressing exceeds 50°C, it will cause irreversible damage to the skin. Figure 8 As shown, the wound dressing prepared in Example 2 is more clinically significant.

[0078] Example 3 Preparation of GO:BGs@PDA 4:2 hydrogel

[0079] According to the process steps of Example 1, the adjustment step 4 is:

[0080] Step 4, preparation of rGO4 / BGs@PDA2: add 2 mg BGs@PDA to 2 mL of 2 mg / mL graphene oxide (GO) dispersion, and disperse it evenly by ultrasound (power of 40 W) for 10 min to obtain a dispersion of rGO4 / BGs@PDA2; continue the reaction to finally obtain a hydrogel containing rGO4 / BGs@PDA2.

[0081] Example 4 Preparation of GO:BGs@PDA 4:4 hydrogel

[0082] According to the process steps of Example 1, the adjustment step 4 is:

[0083] Step 4, preparation of rGO4 / BGs@PDA4: add 4 mg BGs@PDA to 2 mL of 2 mg / mL graphene oxide (GO) dispersion, and disperse it evenly by ultrasound (power of 40 W) for 10 min to obtain a dispersion of rGO4 / BGs@PDA4; continue the reaction to finally obtain a hydrogel containing rGO4 / BGs@PDA4.

[0084] Performance Testing

[0085] 1. Comparison of mechanical strength between comparative example 1 and embodiments 2 and 4

[0086] The mechanical strength of the hydrogels of Comparative Example 1 and Examples 2 and 4 was evaluated using a rotational rheometer. Figure 4 As shown, the storage modulus and loss modulus of Examples 2 and 4 are significantly improved compared with Comparative Example 1, and the introduction of rGO can significantly enhance the mechanical strength of the hydrogel.

[0087] 2. Comparative Example 2 Hydrogel Injectability, Adhesion and Self-Healing Test

[0088] Figure 5This is a diagram showing the verification results of the injectable properties of the hydrogel in Example 2. The results were verified through macroscopic observation and shear thinning experiments using a rheometer. The results showed that the viscosity of the hydrogel decreased significantly with increasing shear rate.

[0089] Figure 6 : is a verification result diagram of the adhesion performance and self-healing performance of the hydrogel in Example 2. Specifically, the adhesion test results of the hydrogel in Example 2 are as follows: Figure 6 A. Self-healing test results Figure 6 B. The storage modulus and loss modulus results under different strain conditions are shown in Figure 6 C. The results show that the prepared hydrogel has excellent adhesion properties to various surfaces and has self-healing properties.

[0090] 3. Comparison of the dispersion and photothermal effects of BGs@PDA and rGO / BGs@PDA in hydrogel

[0091] The dispersion effects of BGs@PDA and rGO / BGs@PDA in hydrogels are as follows Figure 7 As shown in the figure, in the same time, BGs@PDA precipitates at the bottom of the hydrogel before gelation, while rGO / BGs@PDA is still evenly dispersed in the hydrogel solution, and in the same time, the gelation speed of rGO / BGs@PDA hydrogel is faster. The above results show that after rGO is loaded with BGs@PDA, the dispersion effect of BGs@PDA in the hydrogel can be significantly improved.

[0092] The hydrogel was placed in the EP tube and the power was fixed at 0.5 W / cm 2 The temperature change of the hydrogel was tested by irradiating with an 808nm laser and photographing with an infrared thermal imager. Figure 8 As shown, the hydrogel group of comparative example 1 has no photothermal effect, while the BGs@PDA group has a warming effect due to the addition of BGs@PDA, but the warming is weaker and slower than that of the hydrogels of examples 1, 2, 3, and 4. The hydrogel of example 4 has a higher photothermal conversion efficiency than the hydrogel of example 2, indicating that rGO can significantly improve the photothermal conversion efficiency of the hydrogel.

[0093] like Figure 8 As shown, with the increase of rGO content in the hydrogel, the photothermal conversion efficiency is significantly improved, but considering that the body surface temperature exceeding 50°C will cause irreversible damage to the wound, a comprehensive evaluation shows that the components in the hydrogel prepared in Example 2 are in the optimal proportion.

[0094] 4. Verification of the free radical scavenging ability of hydrogels in Comparative Example 1 and Examples 1, 2, 3, and 4

[0095] In the process of wound healing, the scavenging of free radicals helps to reduce inflammatory reactions and oxidative damage. By studying the free radical scavenging ability of hydrogels, their application effect in wound healing can be enhanced. The DPPH free radical scavenging experiment was used to verify the free radical scavenging rate of the hydrogels in Comparative Example 1 and Examples 1, 2, 3, and 4. Fig. 9 The results in A show that compared with comparative example 1, the DPPH scavenging rates of the hydrogels of Examples 1, 2, 3, and 4 are all greater than 50%, indicating that they have good free radical scavenging ability, and the scavenging ability increases with the increase of rGO content.

[0096] 5. Test of Conductive Properties of Hydrogels in Comparative Example 1 and Examples 1, 2, 3, and 4

[0097] Conductive wound dressings can accelerate wound healing by simulating endogenous current in the skin. The conductivity of the hydrogel was tested using a conductive gel resistivity tester. Fig. 9 As shown in Figure B, the conductivity of Examples 1, 2, 3, and 4 is significantly improved compared with Comparative Example 1, and as the rGO content in the system increases, the conductivity also increases.

[0098] 6. Experiment on antibacterial effect of hydrogel in Example 2

[0099] The hydrogels of comparative example 1 and example 2 were subjected to antibacterial experimental tests. The PBS group was used as a blank control group, group I was the hydrogel group of comparative example 1, and group II was the hydrogel group of example 2. The hydrogels of the corresponding groups were respectively treated with 10 5 CFU / mL of Staphylococcus aureus and Escherichia coli were co-cultured for 6 hours. During the culture process, one of the experimental groups was given an additional 808nm near-infrared light irradiation for 120 seconds. After the co-culture, 100μL of the bacterial solution was taken and spread on the nutrient agar medium, and the number of colonies on each plate was counted after culturing at 37℃ for 24 hours. The results are shown in Fig.10 As shown, the hydrogel of Example 2 exhibits good antibacterial ability against both Escherichia coli and Staphylococcus aureus, and after near-infrared light irradiation treatment, the hydrogel of Example 2 has a significant synergistic antibacterial effect against Escherichia coli.

[0100] 7. Hydrogel biocompatibility test

[0101] The hydrogel prepared in Example 2 was immersed in complete culture medium at a concentration of 100 mg / mL for 24 hours to prepare a hydrogel extract. The extract concentrations in the cell experiment were 100 mg / mL, 50 mg / mL, 25 mg / mL, 12.5 mg / mL, 6.25 mg / mL, and 0 mg / mL, respectively. CCK-8 was added after culturing for 24 hours and 48 hours to test the activity of 3T3 cells in the culture medium. The results are shown in FIG. Fig.11As shown in A, the cell viability of 3T3 cells after co-culture with all concentrations of hydrogel extracts for 24 h or 48 h was greater than 80%, and was greater than that of the blank control group.

[0102] The 100 mg / mL, 50 mg / mL, 25 mg / mL, and 12.5 mg / mL extracts prepared from the hydrogel in Example 2 were co-cultured with cells for 24 h and 48 h, and then stained using a cell live / dead staining kit. The results are shown in FIG. Fig.11 As shown in B, compared with the blank control group, when 3T3 cells were co-cultured with different concentrations of extracts for 24 hours or 48 hours, the hydrogel group had no obvious toxicity.

[0103] The 100 mg / mL and 50 mg / mL hydrogel extracts in Example 2 were subjected to a cell scratch test to investigate the effect of the hydrogel in promoting cell proliferation and migration. Fig.11 As shown in C, compared with the blank control group, different concentrations of extracts can promote the migration of cells to the scratch blank area, indicating that the hydrogel prepared in Example 2 can promote cell proliferation and migration.

[0104] The hydrogel extracts of various concentrations in Example 2 were co-incubated with red blood cells to investigate the blood compatibility of the hydrogels. Fig.11 As shown in D, the hemolysis rates of the hydrogel extract groups at each concentration were significantly lower than those of the deionized water group, and were all lower than 5%, indicating that the hydrogel prepared in Example 2 had good anti-hemolysis ability.

[0105] 8. Application of hydrogel in mouse full-thickness section model

[0106] The ICR mice were subjected to full-thickness section modeling. The mice cultured for 8 weeks were anesthetized with isoflurane, and two symmetrical 6mm round holes were punched on the back with a hole puncher, and the prepared hydrogel was attached to the wound. A blank control group was set up, group I was the experimental group using the hydrogel of Example 2 as a dressing, and group II was the experimental group using the hydrogel of Example 2 as a dressing and then irradiated with 808nm near-infrared light. Pictures were taken on days 0, 3, 7, 9, and 14, respectively. The results are shown in the figure. Fig.12 As shown, groups I and II can significantly promote the healing speed of the wound site compared with the blank control group within the same period of time. The hydrogel prepared in Example 2 has the ability to significantly promote wound healing.

Claims

1. A method for preparing an injectable thermosensitive hydrogel wound dressing, It is characterized in that Includes steps: Step 1, after chitosan is dissolved, a soluble silver salt is added, a reducing agent is added dropwise to obtain silver nanoclusters, ethanol is added to precipitate the silver nanoclusters, a cross-linking agent is added to cross-link, and chitosan-wrapped silver nanocluster microspheres AgNCs are obtained by centrifugal purification and freeze-drying; Step 2, mixing silicon dioxide, calcium carbonate, sodium carbonate and phosphorus pentoxide, heating and melting, and quenching with water to obtain silicate-based bioactive glass BGs; Step 3, dissolving dopamine hydrochloride in Tris-hydrochloride buffer, adding silicate-based bioactive glass powder thereto for polymerization reaction, and centrifuging, washing, and drying the product to obtain polydopamine-coated bioactive glass BGs@PDA; Step 4, adding BGs@PDA to the graphene oxide dispersion to mix and undergo redox reaction to obtain rGO / BGs@PDA; Step 5, adding hydroxyethyl cellulose and rGO / BGs@PDA aqueous dispersion to the chitosan solution, then adding the AgNCs in step 1 and mixing, then adding sodium β-glycerophosphate, and stirring the mixed solution in an ice bath to obtain an injectable thermosensitive hydrogel wound dressing.

2. The method for preparing the injectable thermosensitive hydrogel wound dressing according to claim 1, It is characterized in that The soluble silver salt includes one or more of silver nitrate or silver borofluoride; the molar concentration of the silver salt in the solution is 1-5%; The reducing agent includes one or more of sodium borohydride, potassium borohydride, citric acid, and ascorbic acid; the molar concentration of the reducing agent in the solution is 2-10%, and the molar ratio of the reducing agent to the silver ions in the soluble silver salt is 1.5-3:1; The cross-linking agent includes one or more of glutaraldehyde and genipin; the molar concentration of the cross-linking agent in the solution is 0.1-0.5%; In step 1, EDTA is added to adjust the pH of the solution to 3.5-4.5; the molar concentration of EDTA in the solution is 0.5-1%; In step 1, the molecular weight of chitosan is 300-5000Da, and the mass concentration in the solution is 1-5%.

3. The method for preparing the injectable thermosensitive hydrogel wound dressing according to claim 1, It is characterized in that In step 1, the reducing agent is added and the reaction is carried out at room temperature for 1-3 hours; and the cross-linking agent is added and the reaction is carried out at room temperature for 1-4 hours.

4. The method for preparing the injectable thermosensitive hydrogel wound dressing according to claim 1, It is characterized in that In step 2, the mass ratio of silicon dioxide, calcium carbonate, sodium carbonate and phosphorus pentoxide is (40-50):(22-28):(22-28):(2-8); in step 2, the melting temperature is 1000-1300° C. and the melting time is 1-3 h.

5. The method for preparing the injectable thermosensitive hydrogel wound dressing according to claim 1, It is characterized in that In step 3, the mass ratio of dopamine hydrochloride to bioactive glass is 1:2-4; and the polymerization reaction is carried out at room temperature for 8-24 hours.

6. The method for preparing the injectable thermosensitive hydrogel wound dressing according to claim 1, It is characterized in that In step 4, the mass ratio of graphene oxide to BGs@PDA is 1-4:2-4; the mixing includes one or more methods of ultrasound, vortex, and vibration; The ultrasonic treatment is carried out at 50-100W for 10-60min; the vortex treatment time is 10-20min, and the shaking time is 30-60min.

7. The method for preparing the injectable thermosensitive hydrogel wound dressing according to claim 1, It is characterized in that The solvent of the chitosan solution in step 5 is acetic acid; the deacetylation degree of the chitosan in step 5 is ≥95%, and the viscosity is 100-200 mpa.s.

8. The method for preparing the injectable thermosensitive hydrogel wound dressing according to claim 1, It is characterized in that In step 5, the mass ratio of chitosan to hydroxyethyl cellulose is 8-10:1; The mass concentration of chitosan in the mixed solution of step 5 is 1.5-2%; the mass concentration of hydroxyethyl cellulose is 0.1-0.5%; and the mass concentration of sodium β-glycerophosphate is 1-3%; In step 5, after adding different raw materials, stir at room temperature for 30 min-2 h, add sodium β-glycerophosphate and stir and mix at 0-4° C. for 20 min-1 h, and store the product at 0-5° C. for later use.

9. An injectable thermosensitive hydrogel wound dressing prepared according to the preparation method according to any one of claims 1 to 8.

10. Use of the injectable thermosensitive hydrogel wound dressing according to claim 9 in the preparation of medical wound dressing.

Citation Information

Patent Citations

  • Composite hydrogel silver-loaded long-acting antibacterial dressing as well as preparation method and application thereof

    CN114767923A

Cited By

  • Gel and preparation method thereof

    CN119454582A

  • Hydrogen-releasing nanogel for ovarian transplantation protection as well as preparation method and application of hydrogen-releasing nanogel

    CN121265530A

  • Hydrogen-releasing nanogel for ovarian transplantation protection, preparation method and application thereof

    CN121265530B

  • Injectable pH-responsive silk-based photo-thermal antibacterial hydrogel as well as preparation method and application thereof

    CN121944218A

  • Injectable pH-responsive silk-based photothermal antibacterial hydrogel and preparation method and application thereof

    CN121944218B